CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Trends Analyst Outlook Journalist POV

37 hedge funds and large institutions have $28.3M invested in Cellectar Biosciences in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

less funds holding

Funds holding: →

22% less capital invested

Capital invested by funds: $36.3M → $28.3M (-$8.08M)

62% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 13

95% less call options, than puts

Call options by funds: $8K | Put options by funds: $151K

Holders
37
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8K
Puts
$151K
Net Calls
Net Calls Change

Top Buyers

1
+$5.21M
2
+$932K
3
+$523K
4
BlackRock
BlackRock
New York
+$216K
5
Morgan Stanley
Morgan Stanley
New York
+$155K

Top Sellers

1
-$552K
2
-$414K
3
-$392K
4
ACP
Acuta Capital Partners
California
-$182K
5
NA
NewEdge Advisors
Louisiana
-$178K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$37K
27
$35K
28
$27.5K
29
$20K
30
$12.4K
31
$7.12K
32
$2.5K
33
$2.5K
34
$963
35
$255
36
$100
37
$45
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2